Literature DB >> 17240252

Quality of life and health economic assessments of age-related macular degeneration.

David Covert1, Gilles Berdeaux, Jan Mitchell, Clare Bradley, Rod Barnes.   

Abstract

In this article, we review measures of patient-reported outcomes that can show whether a treatment for age-related macular degeneration also provides patient-perceived benefits. In addition, we look at health economic measurements currently being used to develop cost-effectiveness models for age-related macular degeneration.

Entities:  

Mesh：

Year:  2007        PMID： 17240252     DOI： 10.1016/j.survophthal.2006.10.014

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN： 0039-6257            Impact factor:   6.048


  3 in total

1.  Knowledge about the relationship between smoking and blindness in Canada, the United States, the United Kingdom, and Australia: results from the International Tobacco Control Four-Country Project.

Authors:  Ryan David Kennedy; Marlee M Spafford; Carla M Parkinson; Geoffrey T Fong
Journal:  Optometry       Date:  2011-05

Review 2.  Quality of life in age-related macular degeneration: a review of the literature.

Authors:  Jan Mitchell; Clare Bradley
Journal:  Health Qual Life Outcomes       Date:  2006-12-21       Impact factor: 3.186

3.  The intraocular implant and visual rehabilitation improve the quality of life of elderly patients with geographic atrophy secondary to age-related macular degeneration.

Authors:  Jana Nekolova; Jan Kremlacek; Jiri Lukavsky; Radovan Sikl; Martin Sin; Jana Langrova; Jana Szanyi; Nada Jiraskova
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-19       Impact factor: 3.535
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.